Comprehensive genomic profiling (CGP) is reshaping cancer care by enhancing diagnostic accuracy, informing prognosis, and enabling more personalized treatment strategies. Yet, despite its potential, access to CGP remains limited, especially for patients in rural or underserved communities. Challenges such as geographic isolation, infrastructure limitations, and inconsistent reimbursement policies continue to hinder widespread adoption, impacting both patient outcomes and healthcare equity.
In this Inside Precision Medicine roundtable, specialists will explore the current landscape of CGP access, focusing on how geographic and systemic barriers can delay testing, compromise clinical outcomes, and slow integration into routine care. The discussion will highlight practical strategies to expand access, including workflow optimization, digital tools, and collaborative partnerships that support both testing and reimbursement. Attendees will gain insights into how healthcare systems and laboratories are leveraging cloud-based platforms, electronic health records, and educational initiatives to overcome infrastructure challenges and streamline CGP implementation. Real-world case studies will illustrate how institutions are addressing these systemic issues and paving the way for more equitable access to genomic testing.
A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelists.
Produced with support from:
